Alignment Healthcare vs Trupanion
ALHC and TRUP side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALHC and TRUP compare
Alignment Healthcare and Trupanion are about the same size, with market caps of $1.6B and $1.6B.
On earnings, Trupanion is cheaper: it trades at 69.0× trailing earnings, against 69.3× for Alignment Healthcare.
Alignment Healthcare grew revenue faster over the last twelve months (35.9% versus 11.8% for Trupanion).
Alignment Healthcare scores higher on the StockData Score (9 against 6 for Trupanion), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALHC | TRUP |
|---|---|---|
| Size and price | ||
| Market cap | $1.6B | $1.6B |
| Share price | $7.62 | $36.55 |
| Change, 1 year | −53.9% | −3.2% |
| Change, 5 years | −56.1% | −71.2% |
| Beta (5Y) | 0.63 | 0.03 |
| Employees | 1,849 | 1,121 |
| StockData Score | ||
| Total score | 9 (better) | 6 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 3 (better) | 0 |
| Health score | 3 | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 69.3× | 69.0× (better) |
| P/S | 0.3× (better) | 1.1× |
| P/B | 5.8× | 3.9× (better) |
| EV/EBITDA | 15.6× (better) | 33.1× |
| P/FCF | 20.7× | 19.5× (better) |
| FCF yield | 4.8% | 5.1% (better) |
| Fair value | $4.97 | $21.86 |
| Margin of safety | −53.4% (better) | −67.2% |
| Growth | ||
| Revenue growth (TTM) | 35.9% (better) | 11.8% |
| Revenue growth, 5Y average | 32.7% (better) | 23.4% |
| EPS growth (TTM) | – | 104% |
| Profitability | ||
| Gross margin | – | 16.6% |
| Operating margin | 0.88% | 1.6% (better) |
| Net margin | 0.59% | – |
| FCF margin | 1.6% | 5.4% (better) |
| Return on equity | 13.2% | – |
| Return on invested capital | – | 18.9% |
| Financial health | ||
| Debt / equity | 1.17 | 0.26 (better) |
| Net debt / EBITDA | −5.57 | −7.36 |
| Interest coverage | 2.6× (better) | 2.3× |
| Current ratio | 1.71 | 1.77 (better) |
| Altman Z-score | 4.27 (better) | 3.68 |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 106% | 77.1% |
| Held by insiders | 4.6% | 5.7% |
| Insider net buying, 12 months | −$517M | −$3.1M (better) |
| Short interest, % of float | 11.6% | 9.5% |
Go deeper
- ALHC stock overview
- ALHC income statement
- ALHC valuation and score
- TRUP stock overview
- TRUP income statement
- TRUP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.